#Wurst client session trial#

Although 2-5% of all US live births are affected by FASD ( May et al., 2009), pregnant women continue to consume alcohol in amounts risky to the developing fetus with recent prevalence of 7.6 % of pregnant women reporting any alcohol use and 1.4% reporting binge drinking (consuming four or more standard drinks on an occasion) in the previous 30 days ( Marchetta, Denny, Floyd, Cheal, & Sniezek, 2012). Intrauterine alcohol exposure may result in fetal alcohol spectrum disorders (FASD) ( Floyd, OвЂ™Conner, Sokol, Bertrand, & Cordero, 2005 Hoyme et al., 2005 Manning & Hoyme, 2007 Stratton, Howe, & Battaglia, 1996), a leading cause of mental retardation, birth defects and neurodevelopmental disabilities in prenatally exposed children. To prevent fetal alcohol spectrum disorders, future studies will use self-report and biomarkers to more accurately identify women in need of interventions to reduce their risk of alcohol-exposed pregnancies. Although MI was not found effective in decreasing alcohol use, low levels of reported alcohol use by the women at baseline left little room for improvement due to the intervention.

Poisson and linear regression with generalized estimating equations were used to evaluate treatment effects over time. Drinking behaviors, basic psychological need satisfaction, and autonomous motivation to decrease prenatal alcohol use were measured at baseline, 30 day postbaseline, and 30 day postpartum follow-ups.

Eligible pregnant women who drank any amount of alcohol in the previous year (n=122) were randomized to an intervention or comparison group.

#Wurst client session trial#

This randomized clinical trial tested the effectiveness of a single-session of motivational interviewing (MI) to decrease alcohol use during pregnancy, while examining theory-based mechanisms of the intervention.